Mesoblast (MEOBF) director discloses options, warrants and ADS-linked shares

Rhea-AI Filing Summary

Mesoblast Ltd director Philip James Facchina filed an initial Form 3, disclosing his existing equity-linked interests in the company. He reports multiple options (rights to buy Ordinary Shares) with exercise prices of $2.26, $0.36, and $0.97 per share and expirations between 2028 and 2031. He also reports warrants and Ordinary Shares held indirectly through HNP, LLC, a company in which he is a member. The footnotes state that the Ordinary Shares are represented by American Depositary Shares.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

FACCHINA PHILIP JAMES

(Last) (First) (Middle)

LEVEL 38

55 COLLINS STREET

(Street)

MELBOURNE, VICTORIA 3000

(City) (State) (Zip)

AUSTRALIA

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
MESOBLAST LTD [ MESO ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares(1)	123,220	I	Through HNP, LLC, a company in which Mr. Facchina is a member.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Option (right to buy)	04/15/2022	04/14/2028	Ordinary Shares	66,667	$2.26	D
Option (right to buy)	04/15/2023	04/14/2028	Ordinary Shares	66,667	$2.26	D
Option (right to buy)	04/12/2024	10/11/2030	Ordinary Shares	96,811	$0.36	D
Option (right to buy)	04/15/2024	04/14/2028	Ordinary Shares	66,666	$2.26	D
Option (right to buy)	07/12/2024	10/11/2030	Ordinary Shares	96,811	$0.36	D
Option (right to buy)	10/12/2024	10/11/2030	Ordinary Shares	96,810	$0.36	D
Option (right to buy)	02/27/2025	08/26/2031	Ordinary Shares	40,577	$0.97	D
Option (right to buy)	05/27/2025	08/26/2031	Ordinary Shares	40,577	$0.97	D
Option (right to buy)	08/27/2025	08/26/2031	Ordinary Shares	40,577	$0.97	D
Warrants	03/18/2021	03/17/2028	Ordinary Shares	68,306	$2.86	I	Through HNP, LLC, a company in which Mr. Facchina is a member.

Explanation of Responses:

1. Such Ordinary Shares are represented by American Depositary Shares.

Remarks:

1. All exercise prices for options and warrants are in Australian dollars.

	/s/ Philip James Facchina	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does the Mesoblast (MEOBF) Form 3 filing by Philip James Facchina show?

The Form 3 shows initial insider holdings for director Philip James Facchina at Mesoblast. It lists existing options, warrants, and Ordinary Shares, including indirect holdings through HNP, LLC, rather than new market purchases or sales.

What types of securities does Philip James Facchina hold in Mesoblast (MEOBF)?

He holds options to buy Ordinary Shares at various exercise prices and expiration dates, along with warrants and Ordinary Shares held indirectly through HNP, LLC. These positions represent equity-linked incentives and indirect ownership.

Are the Mesoblast (MEOBF) shares held by Philip James Facchina represented by ADSs?

Yes. A footnote states that the Ordinary Shares are represented by American Depositary Shares (ADSs). This means U.S. investors typically trade ADSs that correspond to the underlying Mesoblast Ordinary Shares disclosed in the filing.

Does the Mesoblast (MEOBF) Form 3 indicate recent insider buying or selling?

No specific purchases or sales are identified. The filing classifies entries as holdings with unknown transaction codes, indicating a disclosure of existing positions rather than new buy or sell transactions in Mesoblast securities.

How are HNP, LLC holdings treated in the Mesoblast (MEOBF) Form 3?

The Form 3 shows indirect ownership of warrants and Ordinary Shares through HNP, LLC, described as a company in which Mr. Facchina is a member. These positions are reported separately from his direct option holdings.